Polymers have played an integral role in the advancement of drug delivery technology by
providing controlled release of therapeutic agents in constant doses over long periods …

Herein, we present a survey of the literature covering the development of molecular
imprinting science and technology over the years 2004–2011. In total, 3779 references to …

With the prevalence of electronic devices and an aging population, the number of people
affected with eye disease is increasing year by year. In spite of a large number of eye drops …

Written at a level comprehensible to non-experts, this handbook covers the current state of
encapsulation and controlled released technologies, presenting the fundamental processes …

Contact lenses in the future will likely have functions other than correction of refractive error.
Lenses designed to control the development of myopia are already commercially available …

Glaucoma is the second major cause of blindness in the world after cataract. Glaucoma
management through eye drops that reduce the intraocular pressure (IOP) has major …

Ophthalmic drugs used for the treatment of various ocular diseases are commonly
administered by eye drops. However, due to anatomical and physiological factors, there is a …

Molecular imprinting technology has an enormous potential for creating satisfactory drug
dosage forms. Although its application in this field is just at an incipient stage, the use of …

This paper proposes an approach for increasing drug release durations from contact lenses
and other biomedical devices by in situ creation of transport barriers of Vitamin E that force …

This review presents the current status of molecularly imprinted polymers (MIPs) for drug
delivery, in particular the studies that focus on biocompatibility, cytotoxicity, and in vitro or in …